INTRODUCTION
Eukaryotic elongation factor-2 (eEF-2) mediates the translocation step in the elongation phase of protein synthesis in eukaryotic cells [1] [2] [3] . The activity of this protein can be regulated by phosphorylation mediated by eEF-2 kinase, a highly specific calcium/calmodulin-dependent protein kinase (CaM PK) [4, 5] . The kinase is very specific for eEF.2 -and phosphorylates it on two threonine residues (Thr"5 and Thr58) [6] . The phosphorylation is an ordered process: phosphorylation of Thr56 appears to be a prerequisite for the phosphorylation of Thr58. However, phosphorylation of Thr56 alone seems to inhibit completely the activity of the factor [6] [7] [8] . Phosphorylation of eEF-2 has been observed in vivo under conditions where the cytoplasmic calcium concentration has been raised by hormones and growth factors, or by calcium ionophores [9] [10] [11] .
We have recently purified eEF-2 kinase from rabbit reticulocytes and have shown that it is a monomeric protein of approx. 103 kDa [12] . The kinase undergoes autophosphorylation in a calcium-dependent manner and, in common with CaM PK II [13] and CaM PK IV [14] , autophosphorylation of eEF-2 kinase induces calcium-independent kinase activity. This may have important implications for the control of these kinases in vivo by hormones which raise the cytoplasmic calcium concentration, since the autophosphorylated kinases could continue to be active even after the calcium concentration had returned to basal levels.
Here we show that the catalytic subunit ofcyclic AMP (cAMP)-dependent protein kinase (PKA) can phosphorylate eEF-2 kinase and that this also induces calcium-independent kinase activity. The possible implications of this for the control of eEF-2 kinase are discussed.
EXPERIMENTAL
Chemicals and biochemicals were obtained as before [12, 15] . eEF-2 and eEF-2 kinase were purified from rabbit reticulocytes as described [12] , using CaM-Sepharose in the purification of pendent activity induced by phosphorylation by PKA was similar to that induced by the calcium-stimulated autophosphorylation of eEF-2 kinase. Phosphopeptide mapping of eEF-2 kinase labelled by autophosphorylation and by PKA revealed a number of common phosphopeptides. This suggests that PKA may phosphorylate the same site(s) which are phosphorylated autocatalytically and which are responsible for the induction of calcium-independent activity. The possible implications these findings have for the control of translation are discussed.
eEF-2 kinase. The catalytic subunit of PKA from bovine heart was purified as described [16] , except that an additional Mono S column was used after the hydroxyapatite step. One unit of PKA activity was that which incorporated 1 /tmol of phosphate *min-' into histone 2A under standard assay conditions [16] . The peptide inhibitor of PKA and histone 2A were obtained from Sigma Chemical Co.
eEF-2 kinase activity was measured as described [12] . The assay buffer used here contained no added calcium since there appeared to be enough calcium in the solutions used to maximally activate eEF-2 kinase. In the experiments described below, those incubations which are described as containing calcium contained no added calcium and no EGTA, while those which are described as containing no calcium contained 1 mM EGTA. Two-dimensional phosphopeptide mapping and SDS/PAGE were performed as described [12] . Protein concentrations were determined as described [17] .
RESULTS

Phosphorylaton of eEF-2 kinase by PKA
We have previously reported that eEF-2 kinase undergoes autophosphorylation in the presence of Ca2+/CaM, as shown in Figure l (a) (lane 1). The preparation of eEF-2 kinase used here contained the 103 kDa and 95 kDa forms of the kinase [12] . Autophosphorylation of the kinase decreases the mobility of both forms of the kinase protein on SDS/polyacrylamide gels, leading to the appearance of several radiolabelled bands as can also be seen in Figure l The incorporation of phosphate into eEF-2 kinase by PKA in the absence of calcium was about 7-fold higher than that Abbreviations used: CaM PK, calcium/calmodulin-dependent protein kinase; eEF-2, eukaryotic elongation factor-2; cAMP, cyclic AMP; PKA, cAMPdependent protein kinase. Velocity/l[eEF-2 kinasel (pmol-min1-1uM-1) The induction of eEF-2 kinase calcium-independent activity by PKA phosphorylation was completely abolished by the presence of the PKA inhibitor peptide, showing that the effect on eEF)2 kinase was mediated by PKA phosphorylation, although the inhibitor peptide did have a modest (10-15%) direct inhibitory effect on eEF-2 kinase activity at the concentration used here. It is not clear why this was so, since the sequence around the phosphorylation sites in eEF-2 bears little resemblance to the inhibitor peptide sequence and the latter is therefore unlikely to be acting as a competitive inhibitor of eEF-2 kinase. Under the experimental conditions described, PKA did not directly phosphorylate eEF-2 (results not shown).
Phosphopeptide mapping of eEF-2 kinase phosphorylated by PKA The tryptic phosphopeptide map derived from eEF-2 kinase phosphorylated by PKA to a stoichiometry of about 0.9 molmol-V revealed the presence of a number of phosphopeptides (Figure 4) . Several of the phosphopeptides were also evident in the phosphopeptide map of autophosphorylated eEF-2 kinase (stoichiometry of 3.5 mol -mol-h).
Since autophosphorylation and phosphorylation by PKA induce calcium-independent eEF-2 kinase activity, it is possible that the site(s) phosphorylated in peptides common to eEF-2 kinase phosphorylated by both means may be responsible for the observed effect. Since no sequence data are yet available for eEF-2 kinase, it is impossible to speculate on the sequences around the phosphorylation sites or whether any of the peptides obtained contain recognition motifs for PKA. It is not known why some five or six tryptic phosphopeptides should be obtained from eEF-2 kinase phosphorylated to a stoichiometry of only 0.9 mol mol-1. The labelled eEF-2 kinase was digested twice overnight with trypsin to ensure complete cleavage. Nonetheless, Figure 4 Two-dimensional phosphopeptide mapping of eEF-2 kinase eEF-2 kinase was phosphorylated to a stoichiometry of 0.9 mol mol-1 by PKA in the presence of 1 mM EGTA (a) or was allowed to autophosphorylate in the absence of EGTA to a stoichiometry of 3.5 mol -mol-1 (b). After incubation, the samples were run on an SDS/polyacrylamide gel and the gel chip containing the eEF-2 kinase was subjected to trypsinolysis overnight. The peptides eluted from the gel chips were redigested overnight and two-dimensional phosphopeptide mapping was performed as described. The broken circle indicates the position of a dinitrophenyl-lysine marker and the arrowhead indicates the position of the origin. CHR. and ELEC. refer to the directions of ascending chromatography and electrophoresis respectively. it is possible that the large number of peptides results from partial cleavage around the phosphorylation sites, since phosphorylation close to a cleavage site can partially inhibit the activity of trypsin. Trypsin is likely to cleave close to phosphorylation sites in eEF-2 kinase phosphorylated by PKA, since multiple basic residues form part of the recognition sequence for PKA. Therefore multiple peptides could result containing differing numbers of basic residues at the N-terminus, and since trypsin is not an exopeptidase, an N-terminal basic residue will not be cleaved by trypsin even after prolonged incubation.
Phosphoamino acid analysis showed that PKA phosphorylated eEF-2 kinase exclusively on serine residues (results not shown). [20] . The a-form of phosphorylase kinase is still calcium-dependent, however, since below about 0.1 ,M calcium it is inactive.
DISCUSSION
The catalytic subunit of PKA has also been shown to phosphorylate two other CaM PKs, namely -smooth muscle myosin light chain kinase (SMMLCK) and CaM PK IV. In the case of the former kinase, PKA inhibits SMMLCK since phosphorylation increases the amount of calmodulin required for half-maximal activation some 10-20-fold [21, 22] . Phosphorylation of CaM PK IV by PKA partially inactivates it. However, the remaining activity is still completely calcium-dependent [231.
The possible regulation of protein synthesis by hormones which raise cytoplasmic cAMP concentrations has not been widely studied. However, it has been found that the a-adrenergic agonist, phenylephrine, inhibited protein synthesis in isolated, calcium-depleted, hepatocytes [24] . It was found that there was a close correlation between the abilities of phenylephrine to inhibit protein synthesis and to increase cAMP -concentrations. These authors did not determine whether this inhibition was exerted mainly at the initiation or the elongation stage of peptide synthesis.
Glucagon also increases the cellular cAMP content and inhibits protein synthesis in rat liver [25] [26] [27] . Intriguingly, it was shown that glucagon treatment increased the polypeptide chain completion time and increased the average polysomal size, indicating an inhibition of t-he elongation rate. It was also shown that the initial decrease in protein synthesis correlated well with the increase in cAMP, in that 5 min after glucagon administration, the protein synthesis rate had reached its lowest value and at this time cAMP was maximally elevated. However, after 20 min, protein synthesis had returned to normal while the concentration of cAMP was still elevated, although it was only 36% of the maximum concentration observed [25] . It was suggested that this indicated that changes in cAMP were not directly involved in the control of protein synthesis in the liver by glucagon. Rather [26] . This does not explain, however, why the control exerted by glucagon should occur primarily at the elongation phase of protein synthesis.
Nonetheless, in view of the results presented here, it does seem possible that the activity of eEF-2 kinase and hence protein synthesis could be regulated in vivo by hormones which increase cytoplasmic cAMP. A possible role for the inhibition of protein -synthesis by hormones which raise cAMP could be to divert amino acids away from incorporation into proteins for their use as precursors for gluconeogenesis.
